Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
MDxHealth SA (MDXH)
Company Research
Source: GlobeNewswire
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne IRVINE, CA, and HERSTAL, BELGIUM – September 15, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced the closing of the ExoDx business acquisition from Bio-Techne Corporation, which includes the ExoDx Prostate test. Acquisition of ExoDx Business On August 5, 2025, mdxhealth signed a definitive agreement to acquire Exosome Diagnostics, Inc. from Bio-Techne, including the ExoDx Prostate (EPI) test, CLIA-certified clinical laboratory and related assets. Total consideration for the acquisition is $15 million, with $5 million in stock paid at closing and $2.5 million to be paid annually over the following 4 years with 50% in cash and 50% in cash or stock at mdxhealth’s discretion. XMS Capital Partners acted as sole financial advisor and K&L Gates acted as lead legal counsel to the Company for this acquisition; Baker McKe
Show less
Read more
Impact Snapshot
Event Time:
MDXH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDXH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDXH alerts
High impacting MDxHealth SA news events
Weekly update
A roundup of the hottest topics
MDXH
News
- Institutions profited after MDxHealth SA's (NASDAQ:MDXH) market cap rose US$17m last week but retail investors profited the most [Yahoo! Finance]Yahoo! Finance
- MDxHealth (NASDAQ:MDXH) had its price target raised by analysts at TD Cowen from $5.00 to $7.00. They now have a "buy" rating on the stock.MarketBeat
- MDxHealth (NASDAQ:MDXH) had its price target raised by analysts at Lake Street Capital from $7.00 to $9.00. They now have a "buy" rating on the stock.MarketBeat
- MDxHealth (NASDAQ:MDXH) had its price target raised by analysts at BTIG Research from $6.00 to $7.00. They now have a "buy" rating on the stock.MarketBeat
- MDxHealth SA (MDXH) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
MDXH
Earnings
- 11/12/25 - Miss
MDXH
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/12/25 - Form 6-K
- 9/16/25 - Form 6-K
- MDXH's page on the SEC website